Dr Wenxin Hu
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
16 Scholarly works
0 Projects
HIGHLIGHTS
2024
Journal article
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision
DOI: 10.1126/sciadv.adl07312024
Journal article
Substrate binding plasticity revealed by Cryo-EM structures of SLC26A2
DOI: 10.1038/s41467-024-48028-32024
Journal article
Single-base tiled screen unveils design principles of PspCas13b for potent and off-target-free RNA silencing
DOI: 10.1038/s41594-024-01336-02024
Journal article
CRISPR-Cas13b-mediated suppression of HBV replication and protein expression
DOI: 10.1016/j.jhep.2024.05.0252024
Journal article
Development of PainFace software to simplify, standardize, and scale up mouse grimace analyses
DOI: 10.1097/j.pain.00000000000031872024
Conference Proceedings
CRISPR-Cas13b-mediated suppression of hepatitis B surface antigen-pre-clinical investigations of a new therapeutic approach
DOI: 10.1016/s0168-8278(24)02081-62024
Journal article
Mechanistic Insights Revealed by YbtPQ in the Occluded State
DOI: 10.3390/biom14030322
RECENT SCHOLARLY WORKS
2023
Journal article
A common thalamic hub for general and defensive arousal control
DOI: 10.1016/j.neuron.2023.07.0072023
Journal article
The molecular mechanism of sialic acid transport mediated by Sialin
DOI: 10.1126/SCIADV.ADE83462022
Conference Proceedings
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision
DOI: 10.1016/j.pathol.2021.12.057